Safety of third SARS-CoV-2 vaccine (booster dose) during pregnancy

BACKGROUND: COVID-19 during pregnancy is associated with adverse outcomes for both the mother and fetus. SARS-CoV-2 vaccination has significantly reduced the risk for symptomatic disease. Several studies have reported on the safety of SARS-CoV-2 vaccination during pregnancy, with no adverse effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Dick, Aharon, Rosenbloom, Joshua I., Karavani, Gilad, Gutman-Ido, Einat, Lessans, Naama, Chill, Henry H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988438/
https://www.ncbi.nlm.nih.gov/pubmed/35398583
http://dx.doi.org/10.1016/j.ajogmf.2022.100637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988438/
https://www.ncbi.nlm.nih.gov/pubmed/35398583
http://dx.doi.org/10.1016/j.ajogmf.2022.100637

Ejemplares similares